Advertisement
Advertisement

INDP

INDP logo

Indaptus Therapeutics, Inc. Common Stock

3.29
USD
Sponsored
-0.26
-7.41%
Jun 25, 12:38 UTC -4
Open

INDP Earnings Reports

Positive Surprise Ratio

INDP beat 23 of 40 last estimates.

57%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.60
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
-82.40%

Indaptus Therapeutics, Inc. Common Stock earnings per share and revenue

On May 12, 2026, INDP reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -1.90 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -1.60 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, Indaptus Therapeutics, Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on -- analysts, Indaptus Therapeutics, Inc. Common Stock is expected to report EPS of -$1.60 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement